Clinical Trial Update: Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease [Phase 3]

View source ↗

Summary

Phase 3 study evaluating dextromethorphan/quinidine for irritability in Huntington's disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Irritability

Drugs mentioned

• Dextromethorphan/quinidine (dextromethorphan/quinidine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Huntington Disease, Irritability | Phase 3 | Status: COMPLETED | Results posted: 2024-01-05